JP2011501950A5 - - Google Patents

Download PDF

Info

Publication number
JP2011501950A5
JP2011501950A5 JP2010530910A JP2010530910A JP2011501950A5 JP 2011501950 A5 JP2011501950 A5 JP 2011501950A5 JP 2010530910 A JP2010530910 A JP 2010530910A JP 2010530910 A JP2010530910 A JP 2010530910A JP 2011501950 A5 JP2011501950 A5 JP 2011501950A5
Authority
JP
Japan
Prior art keywords
influenza virus
seq
amino acid
represented
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011501950A (ja
JP5404636B2 (ja
Filing date
Publication date
Priority claimed from KR1020070109535A external-priority patent/KR100850545B1/ko
Application filed filed Critical
Publication of JP2011501950A publication Critical patent/JP2011501950A/ja
Publication of JP2011501950A5 publication Critical patent/JP2011501950A5/ja
Application granted granted Critical
Publication of JP5404636B2 publication Critical patent/JP5404636B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530910A 2007-10-30 2007-11-16 新規のイヌインフルエンザウイルス及びこのワクチン Expired - Fee Related JP5404636B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2007-0109535 2007-10-30
KR1020070109535A KR100850545B1 (ko) 2007-10-30 2007-10-30 신규한 개 인플루엔자 바이러스 및 이의 백신
PCT/KR2007/005789 WO2009057843A1 (en) 2007-10-30 2007-11-16 A novel canine influenza virus and vaccine therefore

Publications (3)

Publication Number Publication Date
JP2011501950A JP2011501950A (ja) 2011-01-20
JP2011501950A5 true JP2011501950A5 (enExample) 2013-06-20
JP5404636B2 JP5404636B2 (ja) 2014-02-05

Family

ID=39881230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530910A Expired - Fee Related JP5404636B2 (ja) 2007-10-30 2007-11-16 新規のイヌインフルエンザウイルス及びこのワクチン

Country Status (8)

Country Link
US (1) US8246962B2 (enExample)
EP (1) EP2078083B1 (enExample)
JP (1) JP5404636B2 (enExample)
KR (1) KR100850545B1 (enExample)
CN (1) CN101605898B (enExample)
AT (1) ATE554789T1 (enExample)
ES (1) ES2383158T3 (enExample)
WO (1) WO2009057843A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
CA2829226C (en) 2011-03-14 2023-01-03 Boehringer Ingelheim Vetmedica, Inc. Equine rhinitis vaccine
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
KR101390554B1 (ko) 2012-05-22 2014-05-21 충남대학교산학협력단 신규한 개 인플루엔자 바이러스(h3n2), 이를 포함하는 백신 조성물 및 h3n2 바이러스 검정 키트
KR101484588B1 (ko) * 2012-10-24 2015-01-20 대한민국 개 인플루엔자 vlp 백신의 제조방법
CN103223162B (zh) * 2013-04-03 2014-07-30 华南农业大学 一株h3n2犬流感病毒株cgd1的应用
KR101511619B1 (ko) * 2013-04-30 2015-04-13 한국생명공학연구원 개 인플루엔자 바이러스 h3n2의 ha1 단백질을 항원으로 포함하는 개 인플루엔자 바이러스 h3n2에 특이적인 혈청 진단용 키트
KR101627623B1 (ko) 2013-08-29 2016-06-08 한국생명공학연구원 이종 인플루엔자 바이러스에 대한 백신 조성물
KR101768600B1 (ko) * 2015-05-18 2017-08-17 한국생명공학연구원 범용성 개 인플루엔자 바이러스 백신 조성물
MX382530B (es) * 2015-06-26 2025-03-13 Boehringer Ingelheim Animal Health Usa Inc Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
WO2017031401A2 (en) * 2015-08-20 2017-02-23 University Of Rochester Ns1 truncated virus for the development of canine influenza vaccines
WO2017031404A1 (en) 2015-08-20 2017-02-23 University Of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
CN105463021A (zh) * 2015-12-25 2016-04-06 华南农业大学 表达h3n2犬流感ha蛋白的重组犬腺病毒疫苗载体的构建方法
CN106248937A (zh) * 2016-09-09 2016-12-21 华中农业大学 一种检测犬副流感病毒抗体的间接elisa试剂盒
MX2020008927A (es) 2018-02-27 2021-01-08 Univ Rochester Vacuna contra la influenza atenuada viva multivalente para la prevencion y el control del virus de la influenza equina (eiv) en caballos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733113B1 (en) * 1994-01-11 2007-05-02 Vlaams Interuniversitair Instituut voor Biotechnologie Influenza vaccine
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
CA2621320C (en) * 2005-10-07 2016-05-24 Pfizer Products Inc. Vaccines and methods to treat canine influenza

Similar Documents

Publication Publication Date Title
JP2011501950A5 (enExample)
JP6663416B2 (ja) イヌにおける呼吸器疾患管理のための材料および方法
Lee et al. Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea
Munch et al. Detection and subtyping (H5 and H7) of avian type A influenza virus by reverse transcription-PCR and PCR-ELISA
Qi et al. Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China
CN101605898B (zh) 新型犬流感病毒及用于它的疫苗
Chan et al. Review of influenza virus vaccines: the qualitative nature of immune responses to infection and vaccination is a critical consideration
Chen et al. Co-circulation of pandemic 2009 H1N1, classical swine H1N1 and avian-like swine H1N1 influenza viruses in pigs in China
Smith et al. Variation in influenza virus genes: epidemiological, pathogenic, and evolutionary consequences
Sun et al. Identification and characterization of avian-origin H3N2 canine influenza viruses in northern China during 2009–2010
El-Zoghby et al. Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in Egypt
Wang et al. Characterization of swine-origin H1N1 canine influenza viruses
Zhao et al. Isolation and phylogenetic analysis of pandemic H1N1/09 influenza virus from swine in Jiangsu province of China
Moon et al. Active reassortment of H9 influenza viruses between wild birds and live-poultry markets in Korea
Sun et al. Pathogenicity and transmission of a swine influenza A (H6N6) virus: Risk assessment of H6N6 swine influenza A virus
Yang et al. Identification and genetic characterization of avian-origin H3N2 canine influenza viruses isolated from the Liaoning province of China in 2012
JP2014511119A (ja) H1n1亜型インフルエンザパンデミックウイルスに対する新型ワクチン
Lee et al. Molecular genetic characteristics of influenza A virus clinically isolated during 2011‐2016 influenza seasons in Korea
Milani et al. Vaccine immune pressure influences viral population complexity of avian influenza virus during infection
Chang et al. Avian influenza virus: the threat of a pandemic
Neumann et al. Viral factors underlying the pandemic potential of influenza viruses
Shahsavandi et al. A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus
Moatasim et al. Impact of individual viral gene segments from influenza A/H5N8 virus on the protective efficacy of inactivated subtype-specific influenza vaccine
Yavarian et al. Characterization of variations in PB2, NS1, M, neuraminidase and hemagglutinin of influenza A (H3N2) viruses in Iran
Kapczynski et al. Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus